Free Trial

IN8bio (INAB) Insider Trading & Ownership

+0.01 (+1.13%)
(As of 06/25/2024 ET)

IN8bio (NASDAQ:INAB) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Amount Of
Insider Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Get INAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling IN8bio stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INAB Insider Buying and Selling by Quarter

IN8bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2023Jeremy R GraffDirectorBuy2,500$0.95$2,375.00  
8/25/2023Patrick MccallCFOBuy1,000$1.03$1,030.00  
8/24/2023William Tai-Wei HoCEOBuy23,800$1.05$24,990.00  
(Data available from 1/1/2013 forward)

INAB Insider Trading Activity - Frequently Asked Questions

Who is on IN8bio's Insider Roster?

The list of insiders at IN8bio includes Emily Fairbairn, Jeremy R Graff, Kate Rochlin, Lawrence Lamb, Patrick Mccall, Trishna Goswami, and William Tai-Wei Ho. Learn more on insiders at INAB.

What percentage of IN8bio stock is owned by insiders?

15.50% of IN8bio stock is owned by insiders. Learn more on INAB's insider holdings.

Which IN8bio insiders have been buying company stock?

The following insiders have purchased INAB shares in the last 24 months: Emily Fairbairn ($1,499,998.70), Jeremy R Graff ($2,375.00), Kate Rochlin ($9,999.70), Lawrence Lamb ($999.40), Patrick Mccall ($1,030.00), Trishna Goswami ($4,998.90), and William Tai-Wei Ho ($74,988.50).

How much insider buying is happening at IN8bio?

Insiders have purchased a total of 851,508 INAB shares in the last 24 months for a total of $1,594,390.20 bought.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:INAB) was last updated on 6/25/2024 by Staff

From Our Partners